Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2019)

Dr Reddys Laboratories (RDY) posted quarterly Interest & Investment Income of -$6.0 million for Q3 2019, down 100.0% on a QoQ basis from -$3.0 million in Q2 2019.

Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2019) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Interest & Investment Income for 4 consecutive years, with -$6.0 million the latest figure, recorded in Q3 2019.

  • Quarterly Interest & Investment Income changed N/A year-over-year to -$6.0 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was -$15.0 million (changed N/A YoY) and the FY2026 annual result came in at $84.0 million, down 4.55% from the prior year.
  • Interest & Investment Income fell to -$6.0 million in Q3 2019 per RDY's latest filing, from -$3.0 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for RDY reached as high as -$3.0 million in Q2 2019 and fell as low as -$6.0 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 32.85 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 41.80 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 28.10 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Dr Reddys Laboratories 9.84 Bn 9.68 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 -6.00 Mn
Jun 30, 2019 -3.00 Mn
Mar 31, 2019 -6.00 Mn
Mar 31, 2014 -1.00
Sep 30, 2010 10.00 Mn
Jun 30, 2010 -7.00 Mn
Mar 31, 2010 -2.00 Mn
Dec 31, 2009 1.00 Mn
Sep 30, 2009 -2.00 Mn
Jun 30, 2009 -6.00 Mn
Mar 31, 2009 -7.00 Mn